ProMed Pharma and DSM Biomedical recently announced a business development partnership focused on polymeric drug delivery.
The collaboration combines ProMed’s micromolding and extrusion capabilities in conjunction with DSM’s biomedical polyurethanes, polyurethaneureas, and bioerodible amino acid-based polyesteramides.
Get the full story on our sister site Medical Design & Outsourcing.